Your browser doesn't support javascript.
loading
A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.
Luomanmäki, K; Grankvist, S; Hallert, C; Jauro, I; Ketola, K; Kim, H C; Kiviniemi, H; Koskivirta, H; Sörskog, L; Vilkko, P.
Affiliation
  • Luomanmäki K; University of Helsinki, Finland.
J Intern Med ; 240(2): 85-92, 1996 Aug.
Article in En | MEDLINE | ID: mdl-8810934
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Heparin / Dalteparin / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 1996 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Heparin / Dalteparin / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Intern Med Journal subject: MEDICINA INTERNA Year: 1996 Document type: Article Affiliation country: Country of publication: